Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-3.39 Insider Own9.50% Shs Outstand41.17M Perf Week-6.73%
Market Cap650.07M Forward P/E- EPS next Y-2.70 Insider Trans-0.66% Shs Float37.26M Perf Month-6.40%
Income-104.32M PEG- EPS next Q-0.84 Inst Own77.34% Short Float17.01% Perf Quarter10.73%
Sales84.30M P/S7.71 EPS this Y0.68% Inst Trans-0.46% Short Ratio10.05 Perf Half Y10.65%
Book/sh-1.11 P/B- EPS next Y23.48% ROA-66.54% Short Interest6.34M Perf Year62.11%
Cash/sh4.00 P/C3.94 EPS next 5Y- ROE- 52W Range8.69 - 24.13 Perf YTD5.27%
Dividend Est.- P/FCF- EPS past 5Y5.89% ROI-179.57% 52W High-34.56% Beta1.12
Dividend TTM- Quick Ratio7.20 Sales past 5Y13144.25% Gross Margin89.53% 52W Low81.70% ATR (14)1.02
Dividend Ex-Date- Current Ratio7.47 EPS Y/Y TTM29.75% Oper. Margin-82.12% RSI (14)47.82 Volatility5.82% 6.05%
Employees201 Debt/Eq- Sales Y/Y TTM24.00% Profit Margin-123.74% Recom1.40 Target Price43.88
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q25.47% Payout- Rel Volume0.62 Prev Close16.64
Sales Surprise-12.20% EPS Surprise-11.93% Sales Q/Q9.24% EarningsMay 13 BMO Avg Volume630.88K Price15.79
SMA20-4.60% SMA505.88% SMA2007.96% Trades Volume393,187 Change-5.11%
Date Action Analyst Rating Change Price Target Change
Feb-08-23Downgrade Jefferies Buy → Hold $35 → $10
Apr-27-22Initiated Berenberg Buy $20
Apr-16-20Reiterated H.C. Wainwright Buy $53 → $57
Apr-13-20Reiterated H.C. Wainwright Buy $75 → $53
Jan-09-20Initiated National Securities Neutral $37
May-30-19Initiated JP Morgan Neutral
May-29-19Initiated Goldman Neutral
Jan-29-19Initiated H.C. Wainwright Buy $82
Nov-08-18Resumed Jefferies Buy
Apr-04-18Upgrade Raymond James Mkt Perform → Outperform
Jul-17-24 09:55AM
Jun-27-24 01:54PM
Jun-17-24 10:51PM
04:05PM Loading…
Jun-13-24 04:05PM
Jun-07-24 08:00AM
Jun-06-24 08:00AM
Jun-05-24 08:00AM
Jun-03-24 08:00AM
May-22-24 08:00AM
May-14-24 08:20AM
May-13-24 12:53PM
08:00AM Loading…
May-07-24 08:00AM
May-05-24 12:20PM
May-04-24 03:20PM
May-03-24 08:00AM
Apr-17-24 12:02PM
Apr-15-24 08:00AM
Apr-03-24 08:00AM
Mar-15-24 10:30AM
Mar-14-24 12:53PM
Mar-08-24 08:00AM
08:00AM Loading…
Mar-04-24 08:00AM
Feb-26-24 08:00AM
Feb-01-24 08:00AM
Jan-24-24 08:00AM
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Dec-08-23 04:00PM
Nov-15-23 01:50PM
Nov-14-23 12:19PM
Nov-13-23 08:00AM
Nov-07-23 08:00AM
Oct-03-23 08:00AM
Sep-11-23 07:00AM
Sep-08-23 08:00AM
Aug-31-23 08:00AM
Aug-18-23 01:40PM
Aug-17-23 07:00AM
Aug-12-23 09:18AM
Aug-10-23 09:55AM
Aug-08-23 08:00AM
Aug-02-23 05:00PM
Aug-01-23 10:05AM
Jul-31-23 08:00AM
Jul-28-23 01:41PM
Jul-27-23 09:55AM
Jul-25-23 04:10PM
Jul-10-23 08:00AM
Jul-06-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 08:00AM
Jun-02-23 08:00AM
May-22-23 01:18PM
May-16-23 12:13PM
May-11-23 09:15AM
May-04-23 08:00AM
May-02-23 10:02AM
May-01-23 02:00PM
Apr-30-23 08:00AM
Apr-25-23 08:00AM
Apr-18-23 12:16PM
Mar-18-23 02:06AM
Mar-16-23 09:15AM
Mar-09-23 04:00PM
Mar-06-23 08:00AM
Mar-01-23 04:00PM
Feb-27-23 08:15AM
Feb-15-23 09:06AM
Feb-06-23 05:33AM
Jan-11-23 08:00AM
Jan-09-23 12:19PM
Dec-19-22 08:00AM
Dec-13-22 12:13PM
Dec-09-22 08:00AM
Dec-02-22 12:00PM
Dec-01-22 07:00PM
Nov-21-22 04:00PM
Nov-16-22 11:24AM
Nov-14-22 08:00AM
Nov-12-22 07:33AM
Nov-10-22 09:15AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-12-22 04:29AM
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoenberg MarkChief Medical OfficerJun 10 '24Sale13.085,15367,401144,284Jun 11 01:15 PM
Schoenberg MarkChief Medical OfficerMar 18 '24Sale14.0512,000168,600139,437Mar 20 04:38 PM
Smith Jason DrewGeneral CounselJan 31 '24Sale15.744,99378,59018,824Feb 02 07:12 PM
Schoenberg MarkChief Medical OfficerJan 31 '24Sale15.743,78959,639149,423Feb 02 07:07 PM
Smith Jason DrewGeneral CounselAug 31 '23Sale18.013,80068,43818,407Sep 05 04:28 PM